Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1802329 Title: FORMULATION PHARMACEUTIQUE COMPRENANT DE L'INSULINE CRISTALLISEE ET DE L'INSULINE EN SOLUTION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
057920522
WO application number:
EP2005055017
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
1802329
WO publication number:
WO2006037789
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
05/10/2005
Grant date:
06/05/2015
EP publication date:
04/07/2007
WO publication date:
13/04/2006
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
06/05/2015
EP B1 publication date:
06/05/2015
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
05/10/2025

Applicant

Name:
Novo Nordisk A/S
Legal Form:
From:
06/05/2015
Address:
Novo Allé, 2880 Bagsværd, Denmark (DK)
To:

Inventor

1

Name:
BERGLUND, Petter
Legal Form:
Address:
S-226 49 Lund, Sweden (SE)

2

Name:
HAMMELEV, Charlotte
Legal Form:
Address:
DK-3520 Farum, Denmark (DK)

3

Name:
ESKILDSEN, Lone
Legal Form:
Address:
DK-3550 Slangerup, Denmark (DK)

4

Name:
MADSEN, Johanne
Legal Form:
Address:
DK-2800 Lyngby, Denmark (DK)

5

Name:
OLSEN, Helle, Aalund
Legal Form:
Address:
DK-2760 Måløv, Denmark (DK)

6

Name:
KIMER, Lone, Løgstrup
Legal Form:
Address:
DK-3520 Farum, Denmark (DK)

Priority

Priority patent number:
200401519
Priority date:
05/10/2004
Priority country:
Denmark (DK)

Classification

IPC or IDT classification:
A61K 38/28; A61P 3/10;

Publication

European Patent Bulletin

Issue number:
201519
Publication date:
06/05/2015
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
02/05/2016
Annual fee number:
11
Annual fee amount:
195 Euro
Penalty fee amount:
210 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type